UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

Haematologica (Roma), 2017-10, Vol.102 (10), p.1629-1639

2017

Volltextzugriff (PDF)

Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?

HemaSphere, 2019-06, Vol.3 (Suppl), p.44-46

2019

Volltextzugriff (PDF)

Natural Killer Cell Hypo‐responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling

HemaSphere, 2019-12, Vol.3 (6), p.e308-n/a

2019

Volltextzugriff (PDF)

Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia

Haematologica (Roma), 2016-11, Vol.101 (11), p.e461-e464

2016

Volltextzugriff (PDF)

Functional Differences Between EBV‐ and CMV‐Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL

HemaSphere, 2020-04, Vol.4 (2), p.e337-n/a

2020

Volltextzugriff (PDF)

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Blood advances, 2019-09, Vol.3 (17), p.2642-2652

2019

Volltextzugriff (PDF)

The biological rationale and clinical efficacy of inhibition of signaling kinases in chronic lymphocytic leukemia

Leukemia research, 2013-07, Vol.37 (7), p.838-847

2013

Volltextzugriff (PDF)

Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes

The Journal of immunology (1950), 2019-10, Vol.203 (8), p.2100-2109

2019

Volltextzugriff (PDF)

A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia

Clinical cancer research, 2021-03, Vol.27 (6), p.1744-1755

2021

Volltextzugriff (PDF)

Abstract 1855: Potent anti-tumor activity against patient CLL, MM and AML by LAVA-051, a bispecific Vγ9Vδ2-T and type 1 NKT cell engager targeting CD1d

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1855-1855

2021

Volltextzugriff (PDF)

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Blood, 2018-11, Vol.132 (21), p.2260-2272

2018

Volltextzugriff (PDF)

Bispecific Vγ9Vδ2-T and Type 1 NKT Cell Engager Lava-051 As First-in-Class Clinical Candidate to Target CD1d Expressing CLL, MM and AML

Blood, 2021-11, Vol.138 (Supplement 1), p.2266-2266

2021

Volltextzugriff (PDF)

First Evidence of Restoration of T and NK Cell Compartment after Venetoclax Treatment

Blood, 2018-11, Vol.132 (Supplement 1), p.1860-1860

2018

Volltextzugriff (PDF)

A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies

Cancer immunology research, 2021-01, Vol.9 (1), p.50-61

2021

Volltextzugriff (PDF)

EBV-Specific CD8+ T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

Blood, 2015-12, Vol.126 (23), p.1723-1723

2015

Volltextzugriff (PDF)

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies

Cell reports. Medicine, 2023-03, Vol.4 (3), p.100961-100961, Article 100961

2023

Volltextzugriff (PDF)

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

Blood, 2015-12, Vol.126 (23), p.2914-2914

2015

Volltextzugriff (PDF)

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline

Cancer, 2018-07, Vol.124 (14), p.2974-2985

2018

Volltextzugriff (PDF)

Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History

Cancer epidemiology, biomarkers & prevention, 2020-01, Vol.29 (1), p.10-21

2020

Volltextzugriff (PDF)

Trunk performance after stroke and the relationship with balance, gait and functional ability

Clinical rehabilitation, 2006-05, Vol.20 (5), p.451-458

2006

Volltextzugriff (PDF)

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Frontiers in pharmacology, 2018-01, Vol.8, p.942-942

2018

Volltextzugriff (PDF)

Mining Fork-Including Software Development Traces

Intelligent Information Systems, 2022, Vol.452, p.100-109

2022

Volltextzugriff (PDF)

Supporting Data-Aware Processes with MERODE

Enterprise, Business-Process and Information Systems Modeling, p.131-146

Volltextzugriff (PDF)

Effect of the serotonin agonist 8-OH-DPAT on the sensorimotor system of the rat

Pharmacology, biochemistry and behavior, 2001-09, Vol.70 (1), p.95-103

2001

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Lancet Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)
Buchkapitel
(2)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(5)
Haematologica
(3)
Hemasphere
(3)
Blood Advances
(1)
Cancer
(1)
Cancer Epidemiology, Biomarkers & Prevention
(1)
Cancer Immunology Research
(1)
Cancer Research
(1)
Cell Reports Medicine
(1)
Cell Reports. Medicine
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?

Natural Killer Cell Hypo‐responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling

Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia

Functional Differences Between EBV‐ and CMV‐Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

The biological rationale and clinical efficacy of inhibition of signaling kinases in chronic lymphocytic leukemia

Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes

A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia

Abstract 1855: Potent anti-tumor activity against patient CLL, MM and AML by LAVA-051, a bispecific Vγ9Vδ2-T and type 1 NKT cell engager targeting CD1d

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Bispecific Vγ9Vδ2-T and Type 1 NKT Cell Engager Lava-051 As First-in-Class Clinical Candidate to Target CD1d Expressing CLL, MM and AML

First Evidence of Restoration of T and NK Cell Compartment after Venetoclax Treatment

A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies

EBV-Specific CD8+ T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline

Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History

Trunk performance after stroke and the relationship with balance, gait and functional ability

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Mining Fork-Including Software Development Traces

Supporting Data-Aware Processes with MERODE

Effect of the serotonin agonist 8-OH-DPAT on the sensorimotor system of the rat

Aktive Filter

Suchergebnisse filtern